Exclusive: TPG-backed Aptalis Pharma hires banks for an IPO - Reuters
Aptalis Pharma, a specialty drugmaker owned by private equity firm TPG Capital, has appointed underwriters for an IPO after efforts to sell the company failed, according to an exclusive Reuters report. Goldman Sachs and JPMorgan will lead the offering.
24 October 2013•2 mins read
